Cohort studyindependent cross-checkabstract checked★ key study I-ABX-112 standard review

Twin study finds no link between baby antibiotics and overweight

Early-life antibiotic use and children with overweight and obesity: a Dutch twin cohort study.

Overview

Feil RS et al.. Int J Obes (Lond) 2026 · PMID 42457938 · DOI 10.1038/s41366-026-02164-6

Among 34,142 Dutch twins, early antibiotics were not linked to overweight or obesity.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Test the antibiotic-weight link while controlling for family

How was the study done?

Twin cohort

How many people, animals or samples were studied?

34,142 twins

What was actually found?

No association

How large was the observed effect?

OR 1.00 (0.90-1.12)

What do the results mean in everyday life?

Earlier links may reflect family factors

What are the study's limitations?

Antibiotic use reported by parents

What does it say about Elawady's specific claim?

Contradicts the claim

Do the results apply to Germany and Europe?

High

What can explicitly not be concluded from this study?

Effects of many courses

Scientific in-depth review

1. Full reference

Authors
Feil RS et al.
Journal
Int J Obes (Lond)
Year
2026
Identifier
PMID 42457938 DOI 10.1038/s41366-026-02164-6
Verification
verified – PubMed efetch 2026-10-26 + Crossref
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Authors' disclosures: one author with advisory fees from GSK, Boehringer Ingelheim and AstraZeneca (record).

2. Research question

Is early-life antibiotic use associated with childhood overweight/obesity after controlling for shared familial factors?

3. Study design and population

Study design
Cohort study – Retrospective twin cohort with co-twin control analysis
Population

Twins aged 4.5-15.4 years in the Netherlands Twin Register

Country

Netherlands

Period

Not stated in abstract

Sample size

34,142 twins

Inclusion and exclusion criteria

Twin register participants with exposure and BMI data

4. Methods and endpoints

Exposure / intervention

Any antibiotic use before age 2 (24.6%)

Comparator

No antibiotic use; co-twin

Endpoints

Obesity, overweight/obesity, BMI z-score

Statistical methods

Adjusted logistic regression; matched co-twin analyses

5. Actual results

Results

No association with obesity (OR 0.82, 95% CI 0.60-1.14) or overweight/obesity (OR 1.00, 0.90-1.12); matched co-twin analyses similar null; BMI z-scores did not differ.

Absolute risks

1.06% obesity, 9.23% overweight/obesity overall

Authors' conclusion

Early-life antibiotic use is not associated with an increased risk of overweight or obesity in childhood.

6. Strengths

  • Large twin design controls shared genes and environment
  • Recent

7. Weaknesses

  • Parent-reported antibiotic use (retrospective)
  • Low obesity prevalence limits power for obesity

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Recall misclassification would bias toward null.

9. Assessment of the statistical interpretation

Null with reasonably narrow CI for overweight/obesity (0.90-1.12).

10. Relevance to the specific claim

Within-family design finds no association.

11. Independent contrary findings

Exposure by questionnaire.

12. Transferability to Germany and Europe

High (European).

13. Overall methodological judgement

Strong contradicting evidence against a causal effect on childhood weight.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Replication with prescription records.

15. Linked fact checks